Courses

Free

IACH Post-EBMT 2026 Roundtable Discussion to summarize and reflect on the key highlights of the meeting – Tuesday, March 31, 2026

Free

Role of supplemental nutritional therapies in cancer patients – Thursday, March 26, 2026

Free

Multiple Myeloma Academy – Journal Club – Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial – Tuesday, March 10, 2026

Free

Supportive care in chronic GVHD – Monday, March 9, 2026

Free

CLL Academy – Management of CLL in real life – Thursday, February 26, 2026

Free

Multiple Myeloma Academy – Journal Club – Daratumumab‐based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study – Monday, February 23, 2026

Free

New medicine approved to treat Chronic Graft-Versus-Host Disease – Wednesday, February 18, 2026

Free

IACH Annual Meeting 2026 Scientific Program course – October 15-17, 2026 – Live Broadcast

Free

Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma – Monday, June 16, 2025

Free

Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain Amyloidosis – Tuesday, October 14, 2025

Free

Using Mass Spectrometry Assays in Multiple Myeloma: Where Do We Stand? – Tuesday, April 22, 2025

Free

Highlights from IMS 2025: A Focus on CELMoDs – Monday, October 20, 2025

Free

Characterization of clonal dynamics using duplex sequencing in donor-recipient pairs decades after hematopoietic cell transplantation – Tuesday, January 21, 2025

Free

CMV recommendations ECIL-10 – Thursday, June 26, 2025

Free

Periodontal Disease Explained: Classification, Treatment, and Hematologic Patient Care – Monday, September 22, 2025

Free

Post-IACH 2025 Roundtable Debate – Monday, October 13, 2025

Free

Evidence-Based Practice and Research Literacy for Nurses in Hematology and Bone Marrow Transplant – Thursday, January 8, 2026

Free

Role of the Microbiota in GVHD and Hematology More Broadly – Wednesday, January 14, 2026

Free

Frontline therapy of CLL: where do we stand? – Wednesday, October 1, 2025

Free

JOURNAL CLUB – Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE – Monday, February 10, 2025

« » page 1 / 5